BREAKINGMulti-Source
Neurocrine nears $2.5bn-plus deal for biotech behind obesity disorder treatment
Financial Times|4/6/2026
N
Neurocrine
2 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
1
Activity (Last 30 Days)
1
2026-04-062026-04-06
Top Publishers
Financial Times1 stories